[Lymph node pathology - an update]

Pathologe. 2013 Feb;34(1):34-44. doi: 10.1007/s00292-012-1706-5.
[Article in German]

Abstract

Immune suppression is a risk factor for malignant lymphoma development. Progress in medical science has increased the numbers of immunosuppressed patients due to organ transplantations or successful treatment of autoimmune diseases. Different forms of immune suppression and the respective lymphoma entities are discussed in this article. Another issue treated are gray zone lymphomas between Hodgkin's lymphoma and diffuse large B cell lymphoma. This category not only represents a diagnostic challenge but also represents more a true biological continuum.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Autoimmune Diseases / drug therapy
  • Autoimmune Diseases / genetics
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / pathology
  • Biomarkers, Tumor / genetics
  • Biopsy
  • Diagnosis, Differential
  • Gene Expression Regulation, Neoplastic / genetics
  • Genetic Markers / genetics
  • Hodgkin Disease / classification
  • Hodgkin Disease / genetics
  • Hodgkin Disease / immunology
  • Hodgkin Disease / pathology
  • Humans
  • Immune Tolerance / immunology
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Lymph Nodes / immunology
  • Lymph Nodes / pathology*
  • Lymphoma / classification
  • Lymphoma / genetics
  • Lymphoma / immunology
  • Lymphoma / pathology*
  • Lymphoma, AIDS-Related / genetics
  • Lymphoma, AIDS-Related / immunology
  • Lymphoma, AIDS-Related / pathology
  • Lymphoma, Large B-Cell, Diffuse / classification
  • Lymphoma, Large B-Cell, Diffuse / genetics
  • Lymphoma, Large B-Cell, Diffuse / pathology
  • Lymphoproliferative Disorders / genetics
  • Lymphoproliferative Disorders / immunology
  • Lymphoproliferative Disorders / pathology
  • Mediastinal Neoplasms / classification
  • Mediastinal Neoplasms / genetics
  • Mediastinal Neoplasms / pathology
  • Postoperative Complications / genetics
  • Postoperative Complications / immunology
  • Postoperative Complications / pathology
  • Prognosis
  • Risk Factors
  • Transplantation Immunology / genetics
  • Transplantation Immunology / immunology

Substances

  • Biomarkers, Tumor
  • Genetic Markers
  • Immunosuppressive Agents